A Comperative Study on Health Sector in South Asia and Middle East Countries (Pharmacovigilance Insights)
The market mesmerized innumerable count of medicine especially in south Asian countries as well in middle east, irrationalities on drug promotional activities, lack of proper monitoring in existing system, failure on to promote individual patient care through proper advices, In simple words, pharmacovigilance insights needs to be elaborated, because the activities related purely on drugs, and no one free from adverse effects. Even in the existing pharmacovigilance system were found under reporting on ADR amongst the health care providers, it needs to develop new dimensional view, and to create public awareness programs on this regards. The illustrated data collected 463 experts in health care field from Middle East and South Asian region, specially emphasized on introspective view of participants’ on reporting adverse drug reaction and indirectly asked general population views on this regards. It needs to address pharmacovigilance system have major role to play improve quality of life, It is concluded that on reporting adverse drug reaction most of the people hesitated in existing facilities due to complicacy in procedure, factors like time constraints, lack awareness about this programs, But almost welcomed if the patient going to report adverse drug reaction directly. Simplicity in procedure is the major concern.
Keywords: Pharmacovigilance, ADR, Quality of Life
2. Fatima Suleman (2010), Pharmacovigilance Who Is Responsible And Why Should We Care South African Pharmaceutical Journal 77(9), 56-58.
3. Mohammed Ahmed Alshakka (2010.) The Importance of the Consumer Pharmacovigilance System in Developing Countries: A Case of Malaysia. Journal of Clinical and Diagnostic Research. 4: 2929-2935.
4. Mireille Gony (2010), Improving Adverse Drug Reaction Reporting in Hospitals Drug Saf; 33 (5).
5. Lisha JJ, Mohammed A (2012).Reporting of Adverse Drug Reaction: An exploratory study among nurses in a teaching hospital in Ajman, UAE.” DARU Journal of Pharmaceutical Sciences: 20(44).
6. Bertram G. Katzung, Susan B. Masters, Anthony J. Trevor Et Al (2013)."Introduction of Therapeutics “Basic & Clinical Pharmacology, 11th Edition
7. R Purushotham Naidu (2013). Causality Assessment: A Brief Insight In To Practices In Pharmaceutical Industry Volume Perspectives In Clinical Research 4(4):233-236.
8. Prashansa Agarwal (2014) Drug Discovery and Development: An Insight In To Pharmacovigilance Journal of Pharmacovigilance, 2(1)
9. Khan MA (2014), Pharmacovigilance in India: A Need Indeed, Journal of Pharmacovigilance J Pharmacovigilance, 2(2).
10. Khan MA (2014), Pharmacovigilance in India: A Need Indeed, Journal of Pharmacovigilance J Pharmacovigilance, 2(2).
11. Banchav Ss (2015) Systematic Review of Drug Utilization Studies & the Use of The Drug Classification System In The WHO-SEARO Region Indian Journal Of Medical Research: 120-129.
12. K. Lakshmi Surekha* , N. Shiva Krishna (2016) Monitoring of Adverse Drug Relations In Sai Srinivasa Hospital, Nalgonda Using Spontaneous Reporting Method, World Journal Of Pharmacy And Pharmaceutical Sciences 5(6): 1212-1223.
13. Scaffidi (2016), “The pregnant woman as a drug orphan: A Global Survey of Registered Clinical trials Pharmacological interventions in Pregnancy” BJOG of International Journal of Obstetrics and Gynecology: 124(1).
14. Inez Reberio Vaz (2016) How to promote adverse drug reaction reports using information system – a systematic review and Meta-analysis, BMC Medical Informatics and Decision Making 16(27).
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).